Q4 2017 Annual Press Conference, and Analysts Call
Our Q4/FY 2017 results have been published on March 8, 2018. On this web page you will find all information.
Type of Event
Conference Call
08 Mar 2018
From 07:00 to 15:00
We achieve targets for 2017 – dividend to increase
- Healthcare and Life Science drive sales growth (+2.0%)
- EBITDA pre (–1.7%) burdened by currency headwinds
- Organic sales growth in all regions
- Progress made in reducing net financial debt
- Dividend proposal € 1.25 (+€ 0.05)
ADDITIONAL INFORMATION & DOWNLOADS
Audio Calls
Annual Report 2017
Downloads
- Annual Report 2017 (PDF)
- Single Entity Report 2017 - Merck KGaA, Darmstadt, Germany (PDF)
- Media presentation (PDF)
- Related News
- Earnings presentation (PDF)
- Summary (PDF)
- Financial Statement (XLS)
- Regional Sector Sales (XLS)
Social Media
We are staying the course
“2017 was a good year for our company. We performed well in a challenging environment and met all ourtargets for the year. We are staying the course and will continue to purposefully implement our innovation-driven growth strategies for Healthcare, Life Science and Performance Materials. In addition, we are resolutely working to quickly lower our acquisition-related debt-to-equity ratio.”
(Stefan Oschmann, CEO and Chairman of the Executive Board)
Related News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany, Achieves Targets for 2017 – Dividend to Increase
Merck KGaA, Darmstadt, Germany met its targets for 2017 and achieved important strategic successes with the approvals of two new medicines.
2018/03/08